Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the ...

Artificial intelligence is rapidly reshaping the modern workforce, and healthcare is no exception. Job reductions continue to accelerate across all industries as economic headwinds persist and ...

The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even ...

Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule ...

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...

The partnership will serve patients across the 21 states Oak Street Health has a footprint in. If an Oak Street Health patient has stage 4 chronic kidney disease or end-stage kidney disease, they’ll ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...

CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing ...

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular ...

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as ...

In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...